Data / Form D filings / Vensun Pharmaceuticals, Inc.
Vensun Pharmaceuticals, Inc.: Form D filings
Vensun Pharmaceuticals, Inc., a pharmaceuticals company in Yardley, PA, filed 4 Form D notices with the SEC between 2012 and 2016. The latest, on December 5, 2016, reports $19.5 million sold of a $22.5 million offering to 10 investors.
Find out what Vensun Pharmaceuticals, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 790 TOWNSHIP LINE RD., SUITE 250, Yardley, PA, 19067
- Phone
- (215) 543-3737
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2012
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1545448
The full lists. Form D filings in Pennsylvania: 987 rows, $49.35, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 5, 2016 | New notice | $22,499,979 | $19,499,991 | $2,999,988 | 10 | Nov 21, 2016 | sec.gov |
| Oct 7, 2015 | New notice | $16,000,000 | $4,000,000 | $12,000,000 | 15 | Sep 25, 2015 | sec.gov |
| Oct 11, 2013 | New notice | $15,809,999 | $10,669,998 | $5,140,001 | 6 | Oct 2, 2013 | sec.gov |
| Mar 28, 2012 | New notice | $5,708,000 | $5,708,000 | $0 | 5 | Mar 14, 2012 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Kamlesh E. Haribhakti | Director | |
| Syed E. Abidi | Director | |
| Michael G. Altman | Director | |
| Hemanshu Pandya | Executive Officer, Director | |
| Jason E. Wild | Director | |
| Edward G. Schutter | Director | |
| Dhananjay G. Wadekar | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
Every Form D from the week of Dec 5, 2016 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Vensun Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.